Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and Pancreatitis

ribavirin has been researched along with Pancreatitis in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (66.67)29.6817
2010's4 (26.67)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Carter, M; Fitzmaurice, MG; Jafri, SM; Nagai, S; Singh, A; Solsrud, K; Yeddula, S1
Blum, R; Kessebohm, K; Pfaundler, N; Stickel, F; Stieger, M1
Aikata, H; Chayama, K; Fujino, H; Fukuhara, T; Hiramatsu, A; Imamura, M; Kan, H; Kawaoka, T; Morio, R; Sasaki, T1
Anikin, VB; Babkin, VA; Galochkina, AV; Ostrouhova, LA; Zarubaev, VV1
Bae, WK; Choi, JW; Kim, JG; Kim, JW; Kim, KA; Lee, JS; Paik, WH; Song, TJ1
El-Shamy, A; Hayashi, Y; Hotta, H; Imoto, S; Kim, SR; Kitai, S; Kudo, M; Mita, K; Muramatsu, A; Sasase, N; Taniguchi, M1
Butt, AA1
Gerber, JG; Glesby, MJ1
Bagri, AS; Dural, AT; Khaoustov, VI; Shtenberg, KM; Tran, T; Yoffe, B1
Anand, BS; Batash, S; Bini, EJ; Chaudhari, S; Dieterich, DT; Park, J; Pimstone, NR1
Bani-Sadr, F; Bentata, M; Cacoub, P; Carrat, F; Goujard, C; Hor, R; Lunel-Fabiani, F; Morand, P; Perronne, C; Pialoux, G; Piroth, L; Pol, S; Rosenthal, E; Salmon-Ceron, D1
Ben Salem, C; Bouraoui, K; Hmouda, H1
Cincin, A; Imeryuz, N; Ozdogan, O; Tahan, V; Tozun, N1
Amrani, N; Benaïssa, A; Guedira, MM; Kabbaj, N; Mohammadi, M; Sentissi, S1
Abad, S; Chauvelot-Moachon, L; Salmon-Céron, D; Silbermann, B; Sogni, P1

Reviews

1 review(s) available for ribavirin and Pancreatitis

ArticleYear
Editorial comment: drug-drug interactions, hepatitis C, and mitochondrial toxicity.
    The AIDS reader, 2003, Volume: 13, Issue:7

    Topics: Acidosis, Lactic; Anti-HIV Agents; Antiviral Agents; Didanosine; DNA, Mitochondrial; Drug Synergism; Hepatitis C; HIV Infections; Humans; Metabolic Clearance Rate; Pancreatitis; Ribavirin

2003

Other Studies

14 other study(ies) available for ribavirin and Pancreatitis

ArticleYear
Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single-Center Experience.
    Transplantation proceedings, 2022, Volume: 54, Issue:7

    Topics: Acute Disease; Antiviral Agents; Heart Transplantation; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin M; Kidney; Pancreatitis; Retrospective Studies; Ribavirin; RNA, Viral; Transplant Recipients

2022
Adding pancreatic panniculitis to the panel of skin lesions associated with triple therapy of chronic hepatitis C.
    Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33, Issue:4

    Topics: Antiviral Agents; Biopsy; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Middle Aged; Oligopeptides; Pancreatitis; Panniculitis; Ribavirin; Skin

2013
[A case of chronic hepatitis C with pancreas divisum and acute pancreatitis during combination treatment with telaprevir/peginterferon/ribavirin].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2014, Volume: 111, Issue:10

    Topics: Acute Disease; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Oligopeptides; Pancreatitis; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2014
Virus-inhibiting activity of dihydroquercetin, a flavonoid from Larix sibirica, against coxsackievirus B4 in a model of viral pancreatitis.
    Archives of virology, 2016, Volume: 161, Issue:4

    Topics: Animals; Antiviral Agents; Dose-Response Relationship, Drug; Enterovirus B, Human; Female; Larix; Mice; Molecular Structure; Pancreas; Pancreatitis; Quercetin; Random Allocation; Ribavirin; Virus Replication

2016
Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C.
    Clinical and molecular hepatology, 2016, Volume: 22, Issue:1

    Topics: Amylases; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Lipase; Middle Aged; Pancreatitis; Polyethylene Glycols; Recombinant Proteins; Republic of Korea; Ribavirin; Tomography, X-Ray Computed

2016
Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum hepatitis C virus RNA, genotype 1b, discontinued on attaining sustained virological response at week 16 after onset of acute pancreatitis.
    Digestion, 2009, Volume: 79, Issue:1

    Topics: Acute Disease; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Pancreatitis; Polyethylene Glycols; Polymerase Chain Reaction; Recombinant Proteins; Ribavirin; RNA, Viral; Viral Load

2009
Fatal lactic acidosis and pancreatitis associated with ribavirin and didanosine therapy.
    The AIDS reader, 2003, Volume: 13, Issue:7

    Topics: Acidosis, Lactic; Anti-HIV Agents; Antiviral Agents; CD4 Lymphocyte Count; Didanosine; Drug Synergism; Drug Therapy, Combination; Fatal Outcome; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pancreatitis; Recombinant Proteins; Ribavirin; Risk Factors; Viral Load

2003
Hyperlipasemia associated with hepatitis C virus.
    Digestive diseases and sciences, 2003, Volume: 48, Issue:8

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Lipase; Liver Function Tests; Male; Middle Aged; Pancreatitis; Retrospective Studies; Ribavirin; Viral Load

2003
Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C.
    Digestive diseases and sciences, 2004, Volume: 49, Issue:6

    Topics: Acute Disease; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pancreatitis; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome

2004
Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy.
    Journal of acquired immune deficiency syndromes (1999), 2005, Sep-01, Volume: 40, Issue:1

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Hyperglycemia; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mitochondria; Multivariate Analysis; Pancreatitis; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Treatment Outcome

2005
Peginterferon and ribavirin for hepatitis C.
    The New England journal of medicine, 2007, Mar-22, Volume: 356, Issue:12

    Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Pancreatitis; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2007
Acute pancreatitis associated with the use of peginterferon.
    Pancreas, 2007, Volume: 34, Issue:4

    Topics: Acute Disease; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Pancreatitis; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2007
[Acute pancreatitis during treatment for chronic viral hepatitis C].
    Gastroenterologie clinique et biologique, 2008, Volume: 32, Issue:3

    Topics: Acute Disease; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Pancreatitis; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2008
Mitochondrial toxic effects and ribavirin.
    Lancet (London, England), 2001, Jun-02, Volume: 357, Issue:9270

    Topics: Adult; Anti-HIV Agents; Antiviral Agents; Didanosine; Drug Interactions; Hepatitis C; HIV Seropositivity; HIV-1; Humans; Middle Aged; Mitochondria; Pancreatitis; Ribavirin

2001